Characterization and Implications of IncP-2A Plasmid pMAS152 Harboring Multidrug Resistance Genes in Extensively Drug-Resistant Pseudomonas aeruginosa
-
Published:2024-03-12
Issue:3
Volume:12
Page:562
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Mei Li1, Song Yang2, Liu Xiao3, Li Kun3, Guo Xu4, Liu Li1, Liu Yang1, Kozlakidis Zisis5ORCID, Cheong Io Hong6, Wang Duochun3ORCID, Wei Qiang1
Affiliation:
1. National Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China 2. Division of Infectious Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China 3. National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China 4. National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China 5. International Agency for Research on Cancer, World Health Organization, 69007 Lyon, France 6. State Key Laboratory of Systems Medicine for Cancer, Centre for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
Abstract
Bacterial antimicrobial resistance (AMR) poses a significant global public health challenge. The escalation of AMR is primarily attributed to the horizontal gene transfer (HGT) of antibiotic resistance genes (ARGs), often facilitated by plasmids. This underscores the critical need for a comprehensive understanding of the resistance mechanisms and transmission dynamics of these plasmids. In this study, we utilized in vitro drug sensitivity testing, conjugation transfer assays, and whole-genome sequencing to investigate the resistance mechanism of an extensively drug-resistant (XDR) Pseudomonas aeruginosa clinical isolate, MAS152. We specifically focused on analyzing the drug-resistant plasmid pMAS152 it harbors and its potential for widespread dissemination. Bioinformatics analysis revealed that MAS152 carries a distinct IncpP-2A plasmid, pMAS152, characterized by a 44.8 kb multidrug resistance (MDR) region. This region houses a 16S rRNA methyltransferase (16S-RMTase) gene, rmtB, conferring high-level resistance to aminoglycoside antibiotics. Notably, this region also contains an extended-spectrum β-Lactamase (ESBL) gene, blaPER-1, and an efflux pump operon, tmexCD-oprJ, which mediate resistance to β-Lactams and quinolone antibiotics, respectively. Such a combination of ARGs, unprecedented in reported plasmids, could significantly undermine the effectiveness of first-line antibiotics in treating P. aeruginosa infections. Investigation into the genetic environment of the MDR region suggests that Tn2 and IS91 elements may be instrumental in the horizontal transfer of rmtB. Additionally, a complex Class I integron with an ISCR1 structure, along with TnAs1, seems to facilitate the horizontal transfer of blaPER-1. The conjugation transfer assay, coupled with the annotation of conjugation-related genes and phylogenetic analysis, indicates that the plasmid pMAS152 functions as a conjugative plasmid, with other genus Pseudomonas species as potential hosts. Our findings provide vital insights into the resistance mechanisms and transmission potential of the XDR P. aeruginosa isolate MAS152, underlining the urgent need for novel strategies to combat the spread of AMR. This study highlights the complex interplay of genetic elements contributing to antibiotic resistance and underscores the importance of continuous surveillance of emerging ARGs in clinical isolates.
Funder
National Key R&D Program of China National Science and Technology Infrastructure of China
Reference44 articles.
1. (2023, October 13). World Health Organization: 10 Global Health Issues to Track in 2021. Available online: https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021. 2. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis;Murray;Lancet,2022 3. O’Neill, J. (2023, November 11). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. London: Review on Antimicrobial Resistance. Available online: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf. 4. (2023, October 15). The World Bank: Drug-Resistant Infections: A Threat to Our Economic Future. Available online: https://www.worldbank.org/en/news/infographic/2016/09/18/drugresistantinfections-a-threat-to-our-economic-future. 5. De Oliveira, D.M.P., Forde, B.M., Kidd, T.J., Harris, P.N.A., Schembri, M.A., Beatson, S.A., Paterson, D.L., and Walker, M.J. (2020). Antimicrobial Resistance in ESKAPE Pathogens. Clin. Microbiol. Rev., 33.
|
|